References
- Stamatovic SM, Johnson AM, Keep RF, and Andjelkovic AV. Junctional proteins of the blood-brain barrier: New insights into function and dysfunction. 2016. Tissue Barriers; 4(1):e1154641 [12p.].
- Hou J, Baker LA, Zhou L, and Klein RS. Viral interactions with the blood-brain barrier: old dog, new tricks. 2016. Tissue Barriers; 4(1):e1142492 [9p.].
- McRae MP. HIV and viral protein effects on the blood brain barrier. 2016. Tissue Barriers; 4(1):e1143543 [6p.].
- Wevers NR and de Vries HE. Morphogens and blood-brain barrier function in health and disease. 2016. Tissue Barriers; 4(1):1090524 [16p.].
- Wilhelm I, Nyúl-Tóth A, Maria Suciu M, Hermenean A, and Krizbai IA. Heterogeneity of the blood-brain barrier. 2016. Tissue Barriers; 4(1):e1143544 [8p.].
- Pandey PK, Sharma AK, and Gupta U. Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking. 2016. Tissue Barriers; 4(1):e1129476 [14p.].
- Greene C and Campbell M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. 2016. Tissue Barriers; 4(1):e1138017 [10p.].
- Grabrucker AM, Ruozi B, Belletti D, Pederzoli F, Forni F, Vandelli MA, and Tosi G. Nanoparticle transport across the blood brain barrier. 2016. Tissue Barriers; 4(1):e1153568 [18p.].
- András IE and Toborek M. Extracellular vesicles of the blood-brain barrier. 2016. Tissue Barriers; 4(1):e1131804 [6p.].
- Aberg C. Quantitative analysis of nanoparticle transport through in vitro blood-brain barrier models. 2016. Tissue Barriers; 4(1):e1143545 [8p.].
- van der Helm MW, van der Meer A, Eijkel J, van den Berg A, and Segerink L. Microfluidic organ-on-chip technology for blood-brain barrier research. 2016. Tissue Barriers; 4(1):e1142493 [13p.].